Økonomisk Ugebrev Lifescience conference – Copenhagen
We will give a presentation and update on Scandion followed by a Q&A session. Watch replay
Loading view.
Interim report Q3 2022
Scandion Oncology will publish its Q3 2022 interim report on Wednesday November 16, 2022, before 09:00 CET. Scandion’s Executive Management will host a webcast and conference call the same day at 10:00 CET presenting the results and a company update. At the end of the presentation there will be a Q&A session. Access to the event can be obtained as follows: LIVE access on Wednesday November 16, 2022, at 10:00 CET Webcast: https://financialhearings.com/event/45864 Dial-in: DK: +4578150110 SE: +46850558354 UK: +443333009266 US: +1 6319131422 PIN US: 42830998# REPLAY access Webcast replay will be available at http://www.scandiononcology.com in the Investors section and at http://www.financialhearings.com For further information please contact: Johnny Stilou, Acting CEO & CFO Phone: +45 2960 3532 E-mail: jos@scandiononcology.com
Redeye Life Science Day
Stockholm , SwedenWatch the presentation here. We will give a presentation and update on Scandion followed by a Q&A session.
Year-end report 2022
Webcast for this event can be found here
Swiss Nordic Bio 2023
Zurich Zurich, SwitzerlandMeet Scandion Oncology at Swiss Nordic Bio 2023
Freeths Annual Life Science Summit
London , United KingdomCEO Francois Martelet will give the keynote address at the conference.
Swiss Biotech Day
Basel Zurich, SwitzerlandMeet Scandion Oncology at Swiss Biotech Day.
Q1 2023 Report
Webcast link
LSX Nordic Congress
Copenhagen , DenmarkCEO Francois Martelet will take part in panel discussion.